Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Sep-Oct;36(6):1429-1432.
doi: 10.12669/pjms.36.6.2963.

A 'benign' extrapyramidal side effect masking a life-threatening neuroleptic malignant syndrome

Affiliations
Case Reports

A 'benign' extrapyramidal side effect masking a life-threatening neuroleptic malignant syndrome

Reinhard Dolp et al. Pak J Med Sci. 2020 Sep-Oct.

Abstract

The neuroleptic malignant syndrome is a rare, life-threatening idiosyncratic reaction to neuroleptic medication. The use of newer antipsychotics combined with its rare incidence has made NMS seem as a complication of the past. Here we report a patient in his early 20s suffering from a psychotic disorder developing a life-threatening neuroleptic malignant syndrome on an inpatient psychiatric ward in Canada without the characteristic overt change in autonomic stability. We review the clinical characteristics to facilitate the early recognition of neuroleptic malignant syndromes and discuss why this condition still is highly relevant for practising physicians.

Keywords: Antipsychotics; EPSE; Extra-pyramidal side effects; NMS; Neuroleptic malignant syndrome; Neuroleptics.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interests: The authors have no conflict of interests to report.

Similar articles

References

    1. Shalev A, Hermesh H, Munitz H. Mortality from neuroleptic malignant syndrome. J Clin Psychiatry. 1989;50:18–25. - PubMed
    1. Velamoor R. Neuroleptic malignant syndrome:A neuro-psychiatric emergency:Recognition, prevention, and management. Asian J Psychiatr. 2017;29:106–109. - PubMed
    1. Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry. 1985;142:1137–1145. - PubMed
    1. Gurrera RJ, Caroff SN, Cohen A, Carroll BT, DeRoos F, Francis A, et al. An international consensus study of neuroleptic malignant syndrome diagnostic criteria using the Delphi method. J Clin Psychiatry. 2011;72:1222–1228. doi:10.4088/JCP.10m06438. - PubMed
    1. Nisijima K. Serotonin syndrome overlapping with neuroleptic malignant syndrome:A case report and approaches for differentially diagnosing the two syndromes. Asian J Psychiatr. 2015;18:100–101. - PubMed

Publication types

LinkOut - more resources